Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 2005
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344
Carrie M Brodmerkel, Reid Huber, Maryanne Covington, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050
Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Plos One
|
April 22, 2020
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
Phillip C C Liu, Holly Koblish, Liangxing Wu, et al.
Cell
|
May 9, 2017
Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy
Nina Cabezas-Wallscheid, Florian Buettner, Pia Sommerkamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2025
The novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphoma
Hedieh Jafari, Fiona Brown-Burke, Betsy Pray, et al.
Nature Communications
|
January 20, 2021
A spatially resolved brain region- and cell type-specific isoform atlas of the postnatal mouse brain
Anoushka Joglekar, Andrey Prjibelski, Ahmed Mahfouz, et al.
Faraday Discussions
|
April 22, 2017
Catalysis for Fuels: general discussion
Hans Niemantsverdriet, Pieter van Helden, Emiel Hensen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 30, 2020
Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase <i>δ</i> Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy
Niu Shin, Matthew Stubbs, Holly Koblish, et al.
Faraday Discussions
|
April 20, 2017
Designing new catalysts for synthetic fuels: general discussion
Katherine Holt, Linda Jewell, Hans Niemantsverdriet, et al.
Cancer Cell
|
May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity
Mengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 2005
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344
Carrie M Brodmerkel, Reid Huber, Maryanne Covington, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050
Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Plos One
|
April 22, 2020
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
Phillip C C Liu, Holly Koblish, Liangxing Wu, et al.
Cell
|
May 9, 2017
Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy
Nina Cabezas-Wallscheid, Florian Buettner, Pia Sommerkamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2025
The novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphoma
Hedieh Jafari, Fiona Brown-Burke, Betsy Pray, et al.
Nature Communications
|
January 20, 2021
A spatially resolved brain region- and cell type-specific isoform atlas of the postnatal mouse brain
Anoushka Joglekar, Andrey Prjibelski, Ahmed Mahfouz, et al.
Faraday Discussions
|
April 22, 2017
Catalysis for Fuels: general discussion
Hans Niemantsverdriet, Pieter van Helden, Emiel Hensen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 30, 2020
Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase <i>δ</i> Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy
Niu Shin, Matthew Stubbs, Holly Koblish, et al.
Faraday Discussions
|
April 20, 2017
Designing new catalysts for synthetic fuels: general discussion
Katherine Holt, Linda Jewell, Hans Niemantsverdriet, et al.
Cancer Cell
|
May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity
Mengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Page
of 7